Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 25, 2021 Filed Oct 27, 2021 20:55 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 46,371 | $9.08 | $421,048.68 |
DisclosureSEC source: 0001192482-21-000746 · edgar.xml · nonDerivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Kompella LLC Disclosed balance after: 229,416 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.36. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 21, 2021 Filed Oct 22, 2021 23:58 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 1,898 | $9.01 | $17,100.98 |
DisclosureSEC source: 0001882178-21-000034 · edgar.xml · nonDerivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Kompella LLC Disclosed balance after: 275,787 F1 · shares: This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.02. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 20, 2021 Filed Oct 20, 2021 22:57 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 1,731 | $9.02 | $15,613.62 |
DisclosureSEC source: 0001879785-21-000010 · edgar.xml · nonDerivative · entry 2 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Kompella LLC Disclosed balance after: 277,685 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.03. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 22:57 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 200,000 | $8.41 | $1,682,000.00 |
DisclosureSEC source: 0001879785-21-000010 · edgar.xml · nonDerivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Kompella LLC Disclosed balance after: 279,416 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $8.12 to $8.81. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 22:56 UTC |
Kumar RameshDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001879785-21-000009 · edgar.xml · derivative · entry 3 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 7,500 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, initially representing a right to purchase 54,000 shares, vests and becomes exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 22:56 UTC |
Kumar RameshDirector
|
SaleCommon Stock | 7,500 | $8.13 | $60,975.00 |
DisclosureSEC source: 0001879785-21-000009 · edgar.xml · nonDerivative · entry 2 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.10 to $8.14. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 22:56 UTC |
Kumar RameshDirector
|
Exercise / conversionCommon Stock | 7,500 | $0.51 | $3,825.00 |
DisclosureSEC source: 0001879785-21-000009 · edgar.xml · nonDerivative · entry 1 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2021 Filed Oct 15, 2021 20:02 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001192482-21-000741 · edgar.xml · derivative · entry 4 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,076,587 Underlying: Common Stock · 125,000 shares Expires 2030-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, initially representing a right to purchase a total of 1,357,145 shares, vests and becomes exercisable annually in equal installments over three years commencing on May 7, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| October 15, 2021 Filed Oct 15, 2021 20:02 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 125,000 | $9.80 | $1,225,000.00 |
DisclosureSEC source: 0001192482-21-000741 · edgar.xml · nonDerivative · entry 2 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,000 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.67 to $10.06. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 15, 2021 Filed Oct 15, 2021 20:02 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 125,000 | $0.33 | $41,250.00 |
DisclosureSEC source: 0001192482-21-000741 · edgar.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2021 Filed Oct 15, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 7,990 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001192482-21-000740 · edgar.xml · derivative · entry 3 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,990 Underlying: Common Stock · 7,990 shares Expires 2029-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, initially representing a right to purchase a total of 23,970 shares, vests and becomes exercisable in equal annual installments over a three year period commencing on October 1, 2020, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| October 15, 2021 Filed Oct 15, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
SaleCommon Stock | 7,990 | $9.96 | $79,580.40 |
DisclosureSEC source: 0001192482-21-000740 · edgar.xml · nonDerivative · entry 2 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,591 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.96 to $9.97. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 15, 2021 Filed Oct 15, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionCommon Stock | 7,990 | $2.19 | $17,498.10 |
DisclosureSEC source: 0001192482-21-000740 · edgar.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:01 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001192482-21-000724 · edgar.xml · derivative · entry 4 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,201,587 Underlying: Common Stock · 125,000 shares Expires 2030-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, initially representing a right to purchase a total of 1,357,145 shares, vests and becomes exercisable annually in equal installments over three years commencing on May 7, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:01 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 125,000 | $7.52 | $940,000.00 |
DisclosureSEC source: 0001192482-21-000724 · edgar.xml · nonDerivative · entry 2 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,000 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.47 to $7.58. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:01 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 125,000 | $0.33 | $41,250.00 |
DisclosureSEC source: 0001192482-21-000724 · edgar.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001192482-21-000669 · edgar.xml · derivative · entry 3 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,170 Underlying: Common Stock · 30,000 shares Expires 2030-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, initially representing a right to purchase a total of 369,256 shares, vests and becomes exercisable in equal annual installments over a three year period, commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
SaleCommon Stock | 30,000 | $7.22 | $216,600.00 |
DisclosureSEC source: 0001192482-21-000669 · edgar.xml · nonDerivative · entry 2 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,591 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.18 to $7.28. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionCommon Stock | 30,000 | $0.34 | $10,200.00 |
DisclosureSEC source: 0001192482-21-000669 · edgar.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 21:28 UTC |
Kompella UdayDirector
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000639 · edgar.xml · derivative · entry 4 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,000 Underlying: Common Stock · 10,000 shares Expires 2031-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, initially representing a right to purchase a total of 126,000 shares, vests and becomes exercisable in equal monthly installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 21:28 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 10,000 | $6.81 | $68,072.00 |
DisclosureSEC source: 0001192482-21-000639 · edgar.xml · nonDerivative · entry 2 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,674 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.76 to $6.85. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 21:28 UTC |
Kompella UdayDirector
|
Exercise / conversionCommon Stock | 10,000 | $1.83 | $18,300.00 |
DisclosureSEC source: 0001192482-21-000639 · edgar.xml · nonDerivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 20:04 UTC |
Kumar RameshDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-21-000636 · edgar.xml · derivative · entry 3 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 7,500 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 20:04 UTC |
Kumar RameshDirector
|
SaleCommon Stock | 7,500 | $6.40 | $48,000.00 |
DisclosureSEC source: 0001192482-21-000636 · edgar.xml · nonDerivative · entry 2 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.38 to $6.45. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 20:04 UTC |
Kumar RameshDirector
|
Exercise / conversionCommon Stock | 7,500 | $0.51 | $3,825.00 |
DisclosureSEC source: 0001192482-21-000636 · edgar.xml · nonDerivative · entry 1 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionOptions (Right to Buy) · Derivative | 31,086 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001192482-21-000633 · edgar.xml · derivative · entry 3 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,170 Underlying: Common Stock · 31,086 shares Expires 2030-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options, initially representing a right to purchase a total of 369,256 shares, vest and become exercisable in equal annual installments over a three year period, commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
SaleCommon Stock | 31,086 | $6.70 | $208,276.20 |
DisclosureSEC source: 0001192482-21-000633 · edgar.xml · nonDerivative · entry 2 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,591 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.66 to $6.77. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:01 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionCommon Stock | 31,086 | $0.34 | $10,569.24 |
DisclosureSEC source: 0001192482-21-000633 · edgar.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2021 Filed Jun 25, 2021 20:17 UTC |
Kompella UdayDirector
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000575 · edgar.xml · derivative · entry 4 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,000 Underlying: Common Stock · 10,000 shares Expires 2031-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 17,500 shares under the option are exercisable. The option, initially representing a right to purchase a total of 126,000 shares, vests and becomes exercisable in equal monthly installments over three years commencing on February 2, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| June 25, 2021 Filed Jun 25, 2021 20:17 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 10,000 | $8.13 | $81,345.00 |
DisclosureSEC source: 0001192482-21-000575 · edgar.xml · nonDerivative · entry 2 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,674 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.07 to $8.20. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 25, 2021 Filed Jun 25, 2021 20:17 UTC |
Kompella UdayDirector
|
Exercise / conversionCommon Stock | 10,000 | $1.83 | $18,300.00 |
DisclosureSEC source: 0001192482-21-000575 · edgar.xml · nonDerivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:25 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001790246-21-000003 · edgar.xml · derivative · entry 3 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,256 Underlying: Common Stock · 31,000 shares Expires 2030-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, initially representing a right to purchase a total of 369,256 shares, vests and becomes exercisable in equal annual installments over a three year period, commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:25 UTC |
Subramanian SanjayChief Financial Officer
|
SaleCommon Stock | 31,000 | $7.00 | $217,000.00 |
DisclosureSEC source: 0001790246-21-000003 · edgar.xml · nonDerivative · entry 2 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,591 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $6.96 to $7.07, inclusive. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:25 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionCommon Stock | 31,000 | $0.34 | $10,540.00 |
DisclosureSEC source: 0001790246-21-000003 · edgar.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:23 UTC |
Potti ManishDirector
|
OtherWarrant (Right to Buy) · Derivative | 95,880 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001797537-21-000002 · edgar.xml · derivative · entry 3 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Scotland Parkway LLC Disclosed balance after: 0 Underlying: Common Stock · 95,880 shares Expires 2026-12-15 F1 · ownership.nature: The Reporting Person is a managing member of Scotland Parkway LLC and has voting and investment power over securities held by Scotland Parkway LLC. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:23 UTC |
Potti ManishDirector
|
SaleCommon Stock | 68,185 | $8.86 | $604,119.10 |
DisclosureSEC source: 0001797537-21-000002 · edgar.xml · nonDerivative · entry 2 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Scotland Parkway LLC Disclosed balance after: 91,124 F2 · kind: On June 15, 2021, the Reporting Person exercised a warrant to purchase 95,880 shares of common stock for $6.30 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Company's withholding of 68,185 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 27,695 shares. The Company also paid $4.89 to the Reporting Person in lieu of a fractional share. F1 · ownership.nature: The Reporting Person is a managing member of Scotland Parkway LLC and has voting and investment power over securities held by Scotland Parkway LLC. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:23 UTC |
Potti ManishDirector
|
OtherCommon Stock | 95,880 | $6.30 | $604,044.00 |
DisclosureSEC source: 0001797537-21-000002 · edgar.xml · nonDerivative · entry 1 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Scotland Parkway LLC Disclosed balance after: 159,309 F1 · ownership.nature: The Reporting Person is a managing member of Scotland Parkway LLC and has voting and investment power over securities held by Scotland Parkway LLC. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 23:22 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 22,800 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001790246-21-000001 · edgar.xml · derivative · entry 7 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326,587 Underlying: Common Stock · 22,800 shares Expires 2030-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, initially exercisable for 1,357,145 shares of common stock, vests annually in equal installments over three years commencing on May 7, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 23:22 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 22,800 | $10.98 | $250,344.00 |
DisclosureSEC source: 0001790246-21-000001 · edgar.xml · nonDerivative · entry 4 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,000 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $10.94 to $11.04, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 23:22 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 22,800 | $0.33 | $7,524.00 |
DisclosureSEC source: 0001790246-21-000001 · edgar.xml · nonDerivative · entry 3 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:21 UTC |
Castillo KirstenDirector
|
SaleCommon Stock | 10,000 | $10.00 | $100,000.00 |
DisclosureSEC source: 0001808806-21-000001 · edgar.xml · nonDerivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:22 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 7,758 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001790246-21-000001 · edgar.xml · derivative · entry 6 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,349,387 Underlying: Common Stock · 7,758 shares Expires 2030-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, initially exercisable for 1,357,145 shares of common stock, vests annually in equal installments over three years commencing on May 7, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:22 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 7,758 | $10.94 | $84,872.52 |
DisclosureSEC source: 0001790246-21-000001 · edgar.xml · nonDerivative · entry 2 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,000 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:22 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 7,758 | $0.33 | $2,560.14 |
DisclosureSEC source: 0001790246-21-000001 · edgar.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 10:10 UTC |
Kompella UdayDirector
|
Exercise / conversionOption (right to buy) · Derivative | 7,191 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001192482-21-000472 · edgar.xml · derivative · entry 4 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,191 shares Expires 2025-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, initially representing a right to purchase a total of 7,191 shares, vested and became exercisable on September 27, 2019. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 10:10 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 7,191 | $8.82 | $63,417.43 |
DisclosureSEC source: 0001192482-21-000472 · edgar.xml · nonDerivative · entry 2 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,674 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.81 to $8.86. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 10:10 UTC |
Kompella UdayDirector
|
Exercise / conversionCommon Stock | 7,191 | $1.88 | $13,519.08 |
DisclosureSEC source: 0001192482-21-000472 · edgar.xml · nonDerivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:07 UTC |
Fernandes PrabhavathiDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000463 · edgar.xml · derivative · entry 6 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: Common Stock · 14,000 shares Expires 2031-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, initially representing a right to purchase a total of 126,000 shares, vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company through the applicable vesting dates. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:07 UTC |
Fernandes PrabhavathiDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001192482-21-000463 · edgar.xml · derivative · entry 5 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,500 Underlying: Common Stock · 19,500 shares Expires 2030-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, initially representing a right to purchase a total of 54,000 shares, vests mothly in equal installments over three years commencing on May 5, 2020, subject to continued service with the Company through the applicable vesting dates. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:07 UTC |
Fernandes PrabhavathiDirector
|
SaleCommom Stock | 14,000 | $8.19 | $114,660.00 |
DisclosureSEC source: 0001192482-21-000463 · edgar.xml · nonDerivative · entry 4 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.18 to $8.20. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.